NDC 49708-521

Flumadine

Flumadine

Flumadine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Caraco Pharma, Inc.. The primary component is Rimantadine Hydrochloride.

Product ID49708-521_3f2752c1-89c7-483d-a974-e47b75ffa259
NDC49708-521
Product TypeHuman Prescription Drug
Proprietary NameFlumadine
Generic NameFlumadine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2009-09-22
Marketing CategoryNDA / NDA
Application NumberNDA019649
Labeler NameCaraco Pharma, Inc.
Substance NameRIMANTADINE HYDROCHLORIDE
Active Ingredient Strength100 mg/1
Pharm ClassesInfluenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 49708-521-88

100 TABLET in 1 BOTTLE (49708-521-88)
Marketing Start Date2009-09-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49708-521-88 [49708052188]

Flumadine TABLET
Marketing CategoryNDA
Application NumberNDA019649
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-09-22
Marketing End Date2017-08-31

Drug Details

Active Ingredients

IngredientStrength
RIMANTADINE HYDROCHLORIDE100 mg/1

Pharmacological Class

  • Influenza A M2 Protein Inhibitor [EPC]
  • M2 Protein Inhibitors [MoA]

Trademark Results [Flumadine]

Mark Image

Registration | Serial
Company
Trademark
Application Date
FLUMADINE
FLUMADINE
73586285 1415548 Live/Registered
HOFFMANN-LA ROCHE INC.
1986-03-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.